The Efficacy and Safety of Golimumab as Third- or Fourth-Line Anti-TNF Therapy in Patients with Refractory Crohn's Disease: A Case Series

Por Russi, Linda, Scharl, Michael, Rogler, Gerhard, Biedermann, Luc
Publicado no Inflamm Intest Dis (2017)